Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019135 |
---|---|
Receipt number | R000022125 |
Scientific Title | GENeral practitioners and Embolism pRevention in NVAF patients treated with RivAroxaban : reaL life evidence |
Date of disclosure of the study information | 2015/09/28 |
Last modified on | 2022/04/11 13:53:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/09/28 15:43:48 | ||
2 | Update | 2015/10/01 12:52:37 | Acronym |
|
3 | Update | 2015/10/01 12:53:51 | Other related information Other related information |
|
4 | Update | 2016/08/30 17:48:26 | Last name of lead principal investigator Last name of lead principal investigator Name of primary person or sponsor Organization |
|
5 | Update | 2017/03/29 11:50:02 | Recruitment status |
|
6 | Update | 2020/03/31 18:14:21 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
7 | Update | 2020/03/31 18:16:34 | Date of IRB Date trial data considered complete |
|
8 | Update | 2020/03/31 18:20:32 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Results Delayed Results Delay Reason Results Delay Reason Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
9 | Update | 2020/10/01 09:44:47 | Date analysis concluded |
|
10 | Update | 2022/04/11 13:53:22 | Email |